Breaking News
May 28, 2018 - Antibody removes Alzheimer’s plaques, in mice
May 28, 2018 - Community paramedicine program for older adults reduced number of 911 calls, improved health
May 28, 2018 - AAP: Congress Urged to Act to Prevent Firearm Deaths
May 28, 2018 - Subjective memory may be marker for cognitive decline
May 28, 2018 - Illinois looks at medical marijuana use for opioid dependence
May 28, 2018 - Specific neurons may cause male aggressiveness
May 28, 2018 - New consensus statement outlines evidence-based medical opinion on abusive head trauma
May 28, 2018 - E-Cigarettes Don’t Help Smokers Quit, But Cash Might
May 28, 2018 - New screening tool developed to assess tanning addiction
May 28, 2018 - Unhappy combination of alcohol, anger, and aggressive behavior
May 28, 2018 - Loyola survey identifies significant group of burn patients with elevated PTSD symptoms
May 28, 2018 - Cancer cells co-opt pain-sensing ‘wasabi receptor’ to survive oxidative stress
May 27, 2018 - New way of grouping atoms could herald novel materials, drugs and computers
May 27, 2018 - Less is more? Gene switch for healthy aging found
May 27, 2018 - Breast cancer survivors do not receive recommended level of screening after surgery
May 27, 2018 - Recommendations Developed for Managing Postpartum Pain
May 27, 2018 - Rheumatoid Arthritis (RA) | Arthritis Basics | Arthritis Types | Arthritis
May 27, 2018 - ‘Life support’ for transplant livers better than freezing: study
May 27, 2018 - Tree nut consumption linked to improved type 2 diabetes health
May 27, 2018 - Income and education gap causes racial differences in health behaviors, study shows
May 27, 2018 - Even at ‘Safe’ Levels, Air Pollution Puts Seniors at Risk
May 27, 2018 - Obstructive sleep apnea linked to thinning of calvaria, skull base
May 27, 2018 - Epigem’s Managing Director sets the bar for life sciences industry at VentureFest
May 27, 2018 - CPAP may reduce resting heart rate in prediabetic patients
May 27, 2018 - Study reveals striking disparities in health care access and quality across most nations
May 27, 2018 - The Yogi masters were right—meditation and breathing exercises can sharpen your mind
May 27, 2018 - SLU researcher aims to find solutions for diabetes patients at risk of hypoglycemia
May 27, 2018 - Scientists uncover the cause of insulin resistance in obesity
May 27, 2018 - $2.3 million NIH grant to support new project on oxytocin neurons and social behavior
May 27, 2018 - Less Driving Tied to Lower Cardiovascular Disease Risk
May 27, 2018 - Genetics Home Reference: LMNA-related congenital muscular dystrophy
May 27, 2018 - Long-term psychological study confirms time is the best medicine against homesickness
May 27, 2018 - Study explores if CPAP treatment can improve sexual QOL for sleep apnea patients
May 27, 2018 - Study investigates role played by brain in prosocial behavior
May 27, 2018 - New Guidelines Mean 1 in 3 Adults May Need Blood Pressure Meds
May 27, 2018 - Cerebrospinal Fluid (CSF) Analysis: MedlinePlus Lab Test Information
May 27, 2018 - Kids in tough neighborhoods head to ER more often
May 27, 2018 - Exercise alters brain’s dopamine system to help treat addiction, study finds
May 27, 2018 - Sepsis patients treated and released from ED for outpatient follow-up experience good outcomes
May 27, 2018 - Initiative cuts overuse of tests, treatments for bronchiolitis
May 27, 2018 - Study links ‘sleep spindles’ to memory reactivation
May 27, 2018 - Scientists develop new method to speed up genome evolution of baker’s yeast
May 27, 2018 - Sunscreen pills are fake says FDA
May 27, 2018 - Study finds increasing wealth gap between households of seniors and families with children
May 27, 2018 - Link between tuberculosis and Parkinson’s disease discovered
May 27, 2018 - Doctors call on health authorities for permission to provide stroke patients with life-saving treatment
May 26, 2018 - Couples who eat seafood-rich diet tend to get pregnant faster
May 26, 2018 - NIH summit presents recommendations to accelerate treatment development for Alzheimer’s disease
May 26, 2018 - Medication-related harm found to be common among older adults, but preventable
May 26, 2018 - Lunaphore and Vitro announce partnership to develop ISH protocols for RNA, DNA targets
May 26, 2018 - Cryoablation Efficacious for Cancer Pain, Review Finds
May 26, 2018 - Link between IBD and Parkinson’s might allow doctors to slow down condition
May 26, 2018 - Study finds fewer than 5% of low-income, urban mothers use prenatal vitamins before pregnancy
May 26, 2018 - California hospitals urge moms to favor breast milk over formula
May 26, 2018 - Most concussion patients do not receive follow-up care after hospital discharge, says study
May 26, 2018 - Lifetime risks of developing Alzheimer’s dementia vary by age, gender
May 26, 2018 - Researchers find novel ways to improve participation in clinical research
May 26, 2018 - Researchers develop methods for measuring free-base nicotine levels in e-cigarettes
May 26, 2018 - AHA: Preterm Birth Could Warn of Mom’s Future Heart Risks
May 26, 2018 - Some calories more harmful than others
May 26, 2018 - Study links cell size with commitment to division
May 26, 2018 - Researchers develop new, rapid blood test to detect liver damage
May 26, 2018 - Researchers discover cascade of immune processes linked to poor outcomes in aggressive breast cancer
May 26, 2018 - New research will use mathematics to solve mysteries in cell biology
May 26, 2018 - Proposed National Resilience Strategy to reverse catastrophic increases in ‘deaths of despair’
May 26, 2018 - Mice remain slim on burger diet
May 26, 2018 - BMC receives $13.5 million award to test methods for delivering childhood anxiety treatment
May 26, 2018 - ‘Right to Try Act’ will not benefit terminally-ill patients
May 26, 2018 - Study reveals novel statistical algorithm to identify potential disease genes
May 26, 2018 - Two genes play vital roles in malignant brain cancer
May 26, 2018 - Study explores link between groundwater lithium and diagnoses of bipolar disorder, dementia
May 26, 2018 - Researchers reveal stimulatory effects of myelin on young neural cells
May 26, 2018 - Small part of cellular protein that helps form long-term memories also drives neurodegeneration
May 26, 2018 - Four-legged friends can have heart issues, too
May 26, 2018 - Scientists create small, self-contained spaces inside mammalian cells
May 26, 2018 - Better Social Support Network Protects Black Men Against HIV
May 26, 2018 - National Heart, Lung, and Blood Institute (NHLBI)
May 26, 2018 - Burnout, depression can affect ophthalmology residents, study finds
May 26, 2018 - Latinos and African Americans more likely to experience serious depression than Whites
May 26, 2018 - Data from past epidemic could help improve response to future Ebola outbreaks
Experimental compound reduces destructive inflammation to improve stroke outcome

Experimental compound reduces destructive inflammation to improve stroke outcome

image_pdfDownload PDFimage_print

An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

Rats consuming compound 21 following a clot-based stroke – the most common type in humans – don’t have a smaller stroke size but do have better memory and movement in its aftermath, says Dr. Adviye Ergul, vascular physiologist and Regents’ Professor in the Department of Physiology at the Medical College of Georgia at Augusta University.

“We don’t see acute neuroprotection, but it definitely affects long-term outcome,” says Ergul, a senior author on the study in the Journal of Cerebral Blood Flow and Metabolism. “We think it will help the recovery and, at this moment, we really have no drugs to do that.”

“Our evidence to date indicates that compound 21 helps directly address lingering inflammation and its destructive impact,” says Dr. Susan Fagan, assistant dean for the University of Georgia College of Pharmacy campus in Augusta, Albert W. Jowdy Professor and Director of the Center for Pharmacy and Experimental Therapeutics at MCG.

In preclinical studies designed more like clinical trials, relatively young and otherwise healthy rats were given a clot in the middle cerebral artery – a common site for big strokes in humans. They received different doses of compound 21 – known to stimulate the angiotensin type 2 receptor, which is thought to reduce inflammation and improve cell survival – for five days, with the first dose given three, six or 24 hours after stroke. Some rats also received the clot buster tPA, still the only medicine approved by the Food and Drug Administration for stroke, at either two or four hours post stroke and compound 21 at three hours.

Neither compound 21 alone or in concert with tPA reduced the size of the stroke, says Fagan, also a senior author of the study. In fact tPA was essentially ineffective in these studies. However rats that got compound 21 had less brain inflammation in the days following a stroke, performed better on cognitive tests and had better nerve and movement function.

The scientists think the compound not only inhibits bad things like inflammation and oxidative stress, but also stimulates good ones like brain derived neurotrophic factor, which is known to help ailing brain cells recover, and production of the blood vessel dilator nitric oxide.

The prevailing thought has been that increasing cognitive decline with time results from additional strokes, Ergul notes. But there is evidence that the first stroke alone can initiate a progressive and lasting inflammatory process that can continue to damage the brain for months or longer.

Today there are no prescribed therapies to tamp down this inflammation and damage, Fagan says of stroke, a leading cause of disability in the United Sates.

“More people are surviving stroke but often with consequences like cognitive deficits and impaired ability to function,” Ergul says.

But even the lowest dose of compound 21 given three hours after stroke resulted in significant improvement in these functions although, conversely, no dose reduced the initial size of the stroke, which is typically determined after about three days. However in subsequent studies, the scientists found compound 21 dampened inflammation when given even 24 hours after stroke.

In their follow up studies, they are giving the compound as far as seven days out – as the stroke moves from the acute to the more chronic stage – ideally to help the immune response be more reparative.

The compound works by stimulating the angiotensin type 2 receptor, a cell receptor known to aid blood vessel dilation, minimize cell death, or apoptosis, and reduce inflammation. The type 2 receptor is expressed less in adults than its antithesis, angiotensin type 1 receptor, which typically mediates the more detrimental effects of the renin-angiotensin system, like high blood pressure and inflammation. In fact, drugs that block the angiotensin type 1 receptor on blood vessels, the heart and other tissues, are among the most prescribed drugs, primarily for high blood pressure and heart failure, she says.

Previous work has indicated that stimulating the angiotensin type 2 receptor could aid stroke recovery and that when the receptor is missing, the size of the brain infarct is larger. Additionally, another drug that increases activity of the receptor, but must be directly injected into the brain, has been shown to improve stroke outcome, the investigators write. Ergul, Fagan and their colleagues looked at an antihypertensive that increased the angiotensin type 2 receptor indirectly by blocking the angiotensin type 1 receptor. But in clinical trials, the drug reduced blood pressure too much.

“We thought that a drug that directly stimulated the angiotensin type 2 receptor – and could be taken by mouth – might work better and decided to look at compound 21,” Fagan says. Even high doses of compound 21, did not affect blood pressure, she and Ergul note, which is important because there is conflicting evidence on whether driving pressure up or down is bad following stroke.

In keeping with their desire for translatable findings, the scientists are now working to answer questions like will the results hold in female rats; only male rats were used in the published study to eliminate the stroke protection high estrogen provides. They also are looking at the compound in the face of existing diseases, like hypertension and diabetes, two major stroke risks, as well as increasing age.

Many stroke therapies that looked promising in the laboratory failed in humans, Ergul says, which has led groups like the National Institutes of Health to push for more rigor in study design and reproducibility of results in preclinical trials. Basically this means ensuring that laboratory studies mimic the clinical scenario as closely as possible. In the case of stroke, they suggest studies should include blinding results, so scientists don’t know which animals got which treatment, randomized enrollment of older animals and looking at the impact of tPA on whatever new therapy is being studies. In the case of the MCG studies, even the stroke cause was more translatable: previous lab studies were in models where the event was caused by clamping or putting a balloon in a big artery in the brain rather than by an actual clot.

Dr. Tauheed Ishrat, associate professor in the Department of Anatomy and Neurobiology at the College of Medicine at the University of Tennessee Health Science Center in Memphis, is the study’s corresponding author. Ishrat was a research assistant scientist working with Fagan at the Augusta campus of the UGA College of Pharmacy when the research was done.

High cholesterol, smoking and obesity are other established risk factors for stroke, the fifth leading cause of death in the U.S., according to the Centers for Disease Control and Prevention.

Source:

https://www.augusta.edu/mcg/

Tagged with:

About author

Related Articles